{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:54:11Z","timestamp":1788872051985,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1006\/bbrc.2001.5954","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T09:50:03Z","timestamp":1032169803000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cell Membrane Transport of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the Liver and Systemic Bioavailability"],"prefix":"10.1006","volume":"289","author":[{"given":"Maria C.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan J.","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Le Couteur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/bbrc.2001.5954_RF1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1006\/bbrc.2001.5954_RF2","first-page":"101","article-title":"Importance of familial Parkinson's disease and parkinsonism to the understanding of nigral degeneration in sporadic Parkinson's disease","volume":"60","author":"Hattori","year":"2000","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1006\/bbrc.2001.5954_RF3","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1212\/WNL.46.5.1275","article-title":"Possible environmental, occupational, and other etiologic factors for Parkinson's disease: A case\u2013control study in Germany","volume":"46","author":"Seidler","year":"1996","journal-title":"Neurology"},{"key":"10.1006\/bbrc.2001.5954_RF4","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1212\/WNL.48.6.1583","article-title":"Environmental risk factors and Parkinson's disease: A case\u2013control study in Taiwan","volume":"48","author":"Liou","year":"1997","journal-title":"Neurology"},{"key":"10.1006\/bbrc.2001.5954_RF5","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/bbrc.2001.5954_RF6","first-page":"287","article-title":"[Parkinsonism induced by MPTP as an experimental model of Parkinson disease: Similarities and differences]","volume":"6","author":"Luquin","year":"1991","journal-title":"Neurologia"},{"key":"10.1006\/bbrc.2001.5954_RF7","first-page":"49","article-title":"MPTP-induced parkinsonism in human and non-human primates\u2014Clinical and experimental aspects","volume":"100","author":"Langston","year":"1984","journal-title":"Acta. Neurol. Scand. Suppl."},{"key":"10.1006\/bbrc.2001.5954_RF8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1006\/bbrc.2001.5954_RF9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001756-200001170-00041","article-title":"MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons","volume":"11","author":"Kowall","year":"2000","journal-title":"NeuroReport"},{"key":"10.1006\/bbrc.2001.5954_RF10","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1471-4159.2000.740721.x","article-title":"Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP","volume":"74","author":"Vila","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1006\/bbrc.2001.5954_RF11","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1006\/bbrc.2001.5954_RF12","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/bbrc.2001.5954_RF13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S0317167100037860","article-title":"The use of the MPTP-treated mouse as an animal model of parkinsonism","volume":"14","author":"Heikkila","year":"1987","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1006\/bbrc.2001.5954_RF14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF03655585","article-title":"Effect of MPTP on brain mitochondrial H2O2 and ATP production and on dopamine and DOPAC in the striatum","volume":"55","author":"Fabre","year":"1999","journal-title":"J. Physiol. Biochem."},{"key":"10.1006\/bbrc.2001.5954_RF15","first-page":"35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1006\/bbrc.2001.5954_RF16","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-0773.1988.tb00914.x","article-title":"Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition","volume":"63","author":"Lyden-Sokolowski","year":"1988","journal-title":"Pharmacol. Toxicol."},{"key":"10.1006\/bbrc.2001.5954_RF17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3565(25)12922-4","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is N-demethylated by cytochromes P450 2D6, 1A2 and 3A4\u2014Implications for susceptibility to Parkinson's disease","volume":"277","author":"Coleman","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/bbrc.2001.5954_RF18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/004982597240802","article-title":"Metabolism of MPTP by cytochrome P4502D6 and the demonstration of 2D6 mRNA in human foetal and adult brain by in situ hybridization","volume":"27","author":"Gilham","year":"1997","journal-title":"Xenobiotica"},{"key":"10.1006\/bbrc.2001.5954_RF19","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0026-895X(25)10184-3","article-title":"Contribution of N-oxygenation to the metabolism of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) by various liver preparations","volume":"29","author":"Cashman","year":"1986","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/bbrc.2001.5954_RF20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0090-9556(25)06924-7","article-title":"Quantitative analysis of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism in isolated rat hepatocytes","volume":"16","author":"Di Monte","year":"1988","journal-title":"Drug. Metab. Dispos."},{"key":"10.1006\/bbrc.2001.5954_RF21","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3565(25)23492-9","article-title":"Entry of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine into the rat brain","volume":"249","author":"Riachi","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/bbrc.2001.5954_RF22","first-page":"73","article-title":"Processing of MTP by monoamine oxidases: Implications for molecular toxicology","volume":"23","author":"Trevor","year":"1987","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1006\/bbrc.2001.5954_RF23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(90)81315-F","article-title":"Mechanism of the neurotoxicity of MPTP. An update","volume":"274","author":"Singer","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1006\/bbrc.2001.5954_RF24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/syn.890180105","article-title":"MPTP-induced oxidative stress and neurotoxicity are age-dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels","volume":"18","author":"Ali","year":"1994","journal-title":"Synapse"},{"key":"10.1006\/bbrc.2001.5954_RF25","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0022-3565(25)22211-X","article-title":"Characterization of hepatic microsomal metabolism as an in vivo detoxication pathway of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice","volume":"246","author":"Chiba","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/bbrc.2001.5954_RF26","first-page":"60","article-title":"Liver enzyme abnormalities in Parkinson's disease","volume":"46","author":"Tanner","year":"1991","journal-title":"Geriatrics"},{"key":"10.1006\/bbrc.2001.5954_RF27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0022-510X(97)00179-2","article-title":"The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: A case\u2013control study and meta-analysis","volume":"153","author":"McCann","year":"1997","journal-title":"J. Neurol. Sci."},{"key":"10.1006\/bbrc.2001.5954_RF28","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/S0140-6736(97)03495-8","article-title":"Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease","volume":"350","author":"Bandmann","year":"1997","journal-title":"Lancet"},{"key":"10.1006\/bbrc.2001.5954_RF29","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(98)03453-9","article-title":"Parkinson's disease, pesticides, and glutathione transferase polymorphisms","volume":"352","author":"Menegon","year":"1998","journal-title":"Lancet"},{"key":"10.1006\/bbrc.2001.5954_RF30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1034\/j.1600-0773.2000.pto870608.x","article-title":"Hepatic disposition of neurotoxins and pesticides","volume":"87","author":"Yang","year":"2000","journal-title":"Pharmacol. Toxicol."},{"key":"10.1006\/bbrc.2001.5954_RF31","first-page":"154","article-title":"The modeling of tracer exchange and sequestration in the liver","volume":"43","author":"Goresky","year":"1984","journal-title":"Fed. Proc."},{"key":"10.1006\/bbrc.2001.5954_RF32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1042\/bst0280131","article-title":"The isolated hepatocyte preparation: 30 years on","volume":"28","author":"Berry","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"10.1006\/bbrc.2001.5954_RF33","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1440-1681.1996.tb01151.x","article-title":"Membrane transport as a determinant of the hepatic elimination of drugs and metabolites","volume":"23","author":"Evans","year":"1996","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1006\/bbrc.2001.5954_RF34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-2000-9391","article-title":"Hepatic secretion of conjugated drugs and endogenous substances","volume":"20","author":"Keppler","year":"2000","journal-title":"Semin. Liver. Dis."},{"key":"10.1006\/bbrc.2001.5954_RF35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1023\/A:1016077517241","article-title":"Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics","volume":"13","author":"Yamazaki","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1006\/bbrc.2001.5954_RF36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2000-8408","article-title":"Transport of drugs across the hepatic sinusoidal membrane: Sinusoidal drug influx and efflux in the liver","volume":"20","author":"Suzuki","year":"2000","journal-title":"Semin. Liver. Dis."},{"key":"10.1006\/bbrc.2001.5954_RF37","series-title":"Hepatic Transport of Drugs and Proteins","author":"Meijer","year":"1991"},{"key":"10.1006\/bbrc.2001.5954_RF38","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1476-5381.1996.tb16067.x","article-title":"Inward transport of [3H]-1-methyl-4-phenylpyridinium in rat isolated hepatocytes: Putative involvement of a P-glycoprotein transporter","volume":"119","author":"Martel","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2001.5954_RF39","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(24)38199-6","article-title":"Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations","volume":"289","author":"Yabuuchi","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/bbrc.2001.5954_RF40","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1124\/mol.51.6.913","article-title":"Cloning and functional expression of a human liver organic cation transporter","volume":"51","author":"Zhang","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1006\/bbrc.2001.5954_RF41","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0022-3565(25)39046-4","article-title":"The neurotoxins 1-methyl-4-phenylpyridinium and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine are substrates for the organic cation transporter in renal brush border membrane vesicles","volume":"242","author":"Sokol","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/bbrc.2001.5954_RF42","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1440-1746.1999.01886.x","article-title":"Molecular aspects of organic compound transport across the plasma membrane of hepatocytes","volume":"14","author":"Kamisako","year":"1999","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1006\/bbrc.2001.5954_RF43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-8278(00)80411-0","article-title":"Hepatobiliary transport","volume":"32","author":"Kullak-Ublick","year":"2000","journal-title":"J. Hepatol."},{"key":"10.1006\/bbrc.2001.5954_RF44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/sj.bjp.0701606","article-title":"Interactions between P-glycoprotein substrates and other cationic drugs at the hepatic excretory level","volume":"123","author":"Smit","year":"1998","journal-title":"Br. J. Pharmacol."},{"key":"10.1006\/bbrc.2001.5954_RF45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/bj3380393","article-title":"Canalicular multispecific organic anion transporter\/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione","volume":"338","author":"Paulusma","year":"1999","journal-title":"Biochem. J."},{"key":"10.1006\/bbrc.2001.5954_RF46","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1021\/js9600540","article-title":"Inhibitors of P-glycoprotein-mediated daunomycin transport in rat liver canalicular membrane vesicles","volume":"85","author":"Kwon","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1006\/bbrc.2001.5954_RF47","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bj3450115","article-title":"Molecular cloning and functional characterization of the mouse organic-anion-transporting polypeptide 1 (Oatp1) and mapping of the gene to chromosome X","volume":"345","author":"Hagenbuch","year":"2000","journal-title":"Biochem. J."},{"key":"10.1006\/bbrc.2001.5954_RF48","first-page":"G1037","article-title":"Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells","volume":"276","author":"Eckhardt","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1006\/bbrc.2001.5954_RF49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0016-5085(99)70463-4","article-title":"Localization and function of the organic anion transporting polypeptide Oatp2 in rat liver","volume":"117","author":"Reichel","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1006\/bbrc.2001.5954_RF50","first-page":"G231","article-title":"Immunologic distribution of an organic anion transport protein in rat liver and kidney","volume":"271","author":"Bergwerk","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1006\/bbrc.2001.5954_RF51","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0022-3565(24)36611-X","article-title":"The neurotoxin 1-methyl-4-phenylpyridinium is a substrate for the canalicular organic cation\/H+ exchanger","volume":"281","author":"Moseley","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X01959546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X01959546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:01:17Z","timestamp":1762092077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X01959546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S0006291X01959546"],"URL":"https:\/\/doi.org\/10.1006\/bbrc.2001.5954","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell Membrane Transport of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the Liver and Systemic Bioavailability","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/bbrc.2001.5954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}